Direkt zum Inhalt
Merck
  • The Osteogenesis Effect and Underlying Mechanisms of Local Delivery of gAPN in Extraction Sockets of Beagle Dogs.

The Osteogenesis Effect and Underlying Mechanisms of Local Delivery of gAPN in Extraction Sockets of Beagle Dogs.

International journal of molecular sciences (2015-10-23)
Hongcheng Hu, Yinfei Pu, Songhe Lu, Kuo Zhang, Yuan Guo, Hui Lu, Deli Li, Xuefen Li, Zichen Li, Yuwei Wu, Zhihui Tang
ZUSAMMENFASSUNG

A plastic and biodegradable bone substitute consists of poly (L-lactic-co-glycolic) acid and 30 wt % β-tricalcium phosphate has been previously fabricated, but its osteogenic capability required further improvement. We investigated the use of globular adiponectin (gAPN) as an anabolic agent for tissue-engineered bone using this scaffold. A qualitative analysis of the bone regeneration process was carried out using μCT and histological analysis 12 weeks after implantation. CBCT (Cone Beam Computed Tomography) superimposition was used to characterise the effect of the different treatments on bone formation. In this study, we also explored adiponectin's (APN) influence on primary cultured human jaw bone marrow mesenchymal stem cells gene expressions involved in the osteogenesis. We found OPEN ACCESS Int. J. Mol. Sci. 2015, 16 24947 that composite scaffolds loaded with gAPN or bone morphogenetic protein 2 (BMP2) exhibited significantly increased bone formation and mineralisation following 12 weeks in the extraction sockets of beagle dogs, as well as enhanced expression of osteogenic markers. In vitro investigation revealed that APN also promoted osteoblast differentiation of primary cultured human jaw bone marrow mesenchymal stem cells (h-JBMMSCs), accompanied by increased activity of alkaline phosphatase, greater mineralisation, and production of the osteoblast-differentiated genes osteocalcin, bone sialoprotein and collagen type I, which was reversed by APPL1 siRNA. Therefore, the composite scaffold loaded with APN exhibited superior activity for guided bone regeneration compared with blank control or Bio-Oss® (a commercially available product). The composite scaffold with APN has significant potential for clinical applications in bone tissue engineering.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Essigsäure, glacial, ACS reagent, ≥99.7%
Sigma-Aldrich
Essigsäure, glacial, ReagentPlus®, ≥99%
Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Essigsäure, glacial, ≥99.99% trace metals basis
Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-Ascorbinsäure, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
Essigsäure -Lösung, suitable for HPLC
Sigma-Aldrich
L-Ascorbinsäure, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L-Ascorbinsäure, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-Ascorbinsäure, 99%
Sigma-Aldrich
L-Ascorbinsäure, reagent grade, crystalline
Sigma-Aldrich
L-Glutamin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
SAFC
L-Glutamin
Sigma-Aldrich
L-Ascorbinsäure, ACS reagent, ≥99%
Supelco
L-Ascorbinsäure, analytical standard
Sigma-Aldrich
Essigsäure, suitable for luminescence, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
L-Ascorbinsäure, meets USP testing specifications
Sigma-Aldrich
L-Ascorbinsäure, reagent grade
Sigma-Aldrich
5α-Androstan-17β-ol-3-on, ≥97.5%
Sigma-Aldrich
Dexamethason, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-Glutamin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-Ascorbinsäure, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
Essigsäure, ≥99.5%, FCC, FG
Sigma-Aldrich
Essigsäure, natural, ≥99.5%, FG
Sigma-Aldrich
L-Ascorbinsäure, FCC, FG
Sigma-Aldrich
L-Ascorbinsäure, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
L-Glutamin, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
L-Glutamin
Sigma-Aldrich
L-Ascorbinsäure, puriss. p.a., ≥99.0% (RT)